Literature DB >> 15577213

The effect of Eriobotrya japonica seed extract on oxidative stress in adriamycin-induced nephropathy in rats.

Atsuhide Hamada1, Saburo Yoshioka, Daisuke Takuma, Junko Yokota, Tailine Cui, Masahiko Kusunose, Mitsuhiko Miyamura, Shojiro Kyotani, Yutaka Nishioka.   

Abstract

Eriobotrya japonica has been used as a medicinal plant for a long time, and its leaves are known to have many physiological actions such as anti-inflammatory, antitussive, and expectoran. In contrast, Eriobotrya japonica seeds are only known to contain amygdalin, and almost no investigations of its pharmacological action have been performed. Moreover, some anticancer agents such as adriamycin cause renal disorders as an adverse effect, and the mechanism of the adverse effect is considered to involve oxidative stress. We have reported that Eriobotrya japonica seed extract has an inhibitory effect on liver disorders. In this study, we prepared a 70% ethanol extract of Eriobotrya japonica seeds and administered the extract to rats with renal disorder induced by a single administration of 7 mg/kg body weight adriamycin, and investigated the usefulness of the extract. Increases in indices of renal function, plasma urea nitrogen, were significantly inhibited in rats treated with the Eriobotrya japonica extract compared to rats treated with tap water. In addition, the renal tissue level of reduced glutathione was significantly high in rats that ingested the extract, while the lipid peroxide levels in plasma and renal tissue were significantly low. However, no effect on renal tissue antioxidative enzymes was observed, suggesting that Eriobotrya japonica seed extract has direct antioxidative action. Based on these findings, Eriobotrya japonica seed extract may be effective in reducing the oxidative stress of adriamycin-induced renal disorder. Therefore, ingestion of Eriobotrya japonica seed extract may contribute to a reduction of the adverse effects of adriamycin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15577213     DOI: 10.1248/bpb.27.1961

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  7 in total

1.  Ameliorative effects of Eriobotrya japonica seed extract on cellular aging in cultured rat fibroblasts.

Authors:  Kazuyo Muramoto; Rong-Dan Quan; Toshiharu Namba; Shojiro Kyotani; Mitsuhiko Miyamura; Yutaka Nishioka; Keiichi Tonosaki; Yoshinori L Doi; Hideto Kaba
Journal:  J Nat Med       Date:  2010-12-25       Impact factor: 2.343

2.  Eriobotrya japonica seed extract and deep sea water protect against indomethacin-induced gastric mucosal injury in rats.

Authors:  Junko Yokota; Taisuke Kitaoka; Kohei Jobu; Daisuke Takuma; Atsuhide Hamada; Masahide Onogawa; Saburo Yoshioka; Shojiro Kyotani; Mitsuhiko Miyamura
Journal:  J Nat Med       Date:  2010-07-17       Impact factor: 2.343

3.  Gastroprotective activity of Eriobotrya japonica seed extract on experimentally induced gastric lesions in rats.

Authors:  Junko Yokota; Daisuke Takuma; Atsuhide Hamada; Masahide Onogawa; Saburo Yoshioka; Masahiko Kusunose; Mitsuhiko Miyamura; Shojiro Kyotani; Yutaka Nishioka
Journal:  J Nat Med       Date:  2007-10-02       Impact factor: 2.343

Review 4.  Biological Activities of Extracts from Loquat (Eriobotrya japonica Lindl.): A Review.

Authors:  Yilong Liu; Wenna Zhang; Changjie Xu; Xian Li
Journal:  Int J Mol Sci       Date:  2016-12-06       Impact factor: 5.923

5.  Evaluation of the effective dose of amygdalin for the improvement of antioxidant gene expression and suppression of oxidative damage in mice.

Authors:  Sarah Albogami; Aziza Hassan; Nibal Ahmed; Alaa Alnefaie; Afnan Alattas; Lama Alquthami; Afaf Alharbi
Journal:  PeerJ       Date:  2020-05-21       Impact factor: 2.984

6.  Cobrotoxin from Naja naja atra Venom Ameliorates Adriamycin Nephropathy in Rats.

Authors:  Shu-Zhi Wang; Yin-Li Xu; Qi Zhu; Jian-Qun Kou; Zheng-Hong Qin
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-11       Impact factor: 2.629

7.  Protection Effect of Zhen-Wu-Tang on Adriamycin-Induced Nephrotic Syndrome via Inhibiting Oxidative Lesions and Inflammation Damage.

Authors:  Chun-Ling Liang; Jun-Biao Wu; Jie-Mei Lai; Shu-Fang Ye; Jin Lin; Hui Ouyang; Janis Ya-Xian Zhan; Jiu-Yao Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-09       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.